Inflammation, glucocorticoids and risk of cardiovascular disease

被引：0
|
作者：
Frank Buttgereit
Gerd-Rüdiger Burmester
Brian J Lipworth
机构：
[1] Charité University Medicine,F Buttgereit is Professor of Rheumatology and G
[2] Berlin,R Burmester is Professor of Medicine in the Department of Rheumatology and Clinical Immunology
[3] Germany.,BJ Lipworth is Professor of Allergy and Respiratory Medicine and Head of the Asthma and Allergy Research Group in the Department of Clinical Pharmacology and Therapeutics
[4] University of Dundee School of Medicine,undefined
[5] Dundee,undefined
[6] Scotland,undefined
[7] UK.,undefined
来源：
Nature Clinical Practice Rheumatology | 2009年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A considerable increase in the risk of developing cardiovascular disease is conveyed not only by inflammation, but also by the use of glucocorticoids to treat inflammation. In this Viewpoint, the authors discuss the challenge of balancing the relative benefits and hazards of glucocorticoid treatment for inflammatory diseases, as well as the tantalizing prospect of identifying subgroups of the population at risk for cardiovascular disease.
引用
收藏
页码：18 / 19
页数：1
相关论文
共 50 条
  • [1] Inflammation, glucocorticoids and risk of cardiovascular disease
    Buttgereit, Frank
    Burmester, Gerd-Ruediger
    Lipworth, Brian J.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2009, 5 (01): : 18 - 19
  • [2] Inflammation, aspirin, and the risk of cardiovascular disease
    Bruno, JJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06): : 422 - 422
  • [3] Periodontal Inflammation and the Risk of Cardiovascular Disease
    Aditi Priyamvara
    Amit K. Dey
    Dhrubajyoti Bandyopadhyay
    Veena Katikineni
    Raja Zaghlol
    Binaya Basyal
    Kirolos Barssoum
    Rula Amarin
    Deepak L. Bhatt
    Carl J. Lavie
    Current Atherosclerosis Reports, 2020, 22
  • [4] Periodontal Inflammation and the Risk of Cardiovascular Disease
    Priyamvara, Aditi
    Dey, Amit K.
    Bandyopadhyay, Dhrubajyoti
    Katikineni, Veena
    Zaghlol, Raja
    Basyal, Binaya
    Barssoum, Kirolos
    Amarin, Rula
    Bhatt, Deepak L.
    Lavie, Carl J.
    CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (07)
  • [5] Glucocorticoids and cardiovascular disease
    Walker, Brian R.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 157 (05) : 545 - 559
  • [6] High-dose glucocorticoids increase cardiovascular disease risk
    Reactions Weekly, 2004, 1031 (1) : 4 - 4
  • [7] Periodontal Disease, Systemic Inflammation and the Risk of Cardiovascular Disease
    Francisco Carrizales-Sepulveda, Edgar
    Ordaz-Farias, Alejandro
    Vera-Pineda, Raymundo
    Flores-Ramirez, Ramiro
    HEART LUNG AND CIRCULATION, 2018, 27 (11): : 1327 - 1334
  • [8] Glucocorticoids and Cardiovascular Risk Factors
    Strohmayer, Erika A.
    Krakoff, Lawrence R.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2011, 40 (02) : 409 - +
  • [9] Glucocorticoids, hypertension and cardiovascular risk
    Whitworth, Judith A.
    JOURNAL OF HYPERTENSION, 2006, 24 : 66 - 66
  • [10] Targeting inflammation to reduce cardiovascular disease risk
    Maffia, Pasquale
    Cirino, Giuseppe
    BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (22) : 3895 - 3897
12345